David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
City Holding Co
CHCO
$2.04B
| $272K | ﹤0.01% |
3,320
-514
| -13% | -$40.7K |
|
3627
Chubb
CB
$133B
| $271K | ﹤0.01% |
1,744
-100
| -5% | -$15.3K |
|
3628
Applied Industrial Technologies
AIT
$12.4B
| $270K | ﹤0.01% |
4,048
-43,764
| -92% | -$2.68M |
|
3629
McCormick & Company Non-Voting
MKC
$15.1B
| $270K | ﹤0.01% |
+3,178
| New | +$263K |
|
3630
Select Water Solutions
WTTR
$2.48B
| $270K | ﹤0.01% |
+29,069
| New | +$235K |
|
3631
Group 1 Automotive
GPI
$3.09B
| $268K | ﹤0.01% |
+2,684
| New | +$265K |
|
3632
Kadant
KAI
$3.69B
| $268K | ﹤0.01% |
2,543
-66
| -3% | -$6.27K |
|
3633
FreightCar America
RAIL
$234M
| $268K | ﹤0.01% |
129,472
+57,594
| +80% | +$173K |
|
|
NPKI
3634
NPK International
NPKI
$1.12B
| $268K | ﹤0.01% |
+42,640
| New | +$278K |
|
3635
Cavco Industries
CVCO
$4.48B
| $267K | ﹤0.01% |
1,365
+100
| +8% | +$19.6K |
|
|
CUTR
3636
DELISTED
Cutera, Inc.
CUTR
| $267K | ﹤0.01% |
7,447
-84,609
| -92% | -$2.86M |
|
|
CMLS
3637
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $267K | ﹤0.01% |
+15,182
| New | +$233K |
|
3638
Construction Partners
ROAD
$6.16B
| $266K | ﹤0.01% |
+15,738
| New | +$276K |
|
|
TTOO
3639
DELISTED
T2 Biosystems, Inc
TTOO
| $266K | ﹤0.01% |
+46
| New | +$435K |
|
|
CYBE
3640
DELISTED
Cyberoptics Corp
CYBE
| $266K | ﹤0.01% |
+14,468
| New | +$246K |
|
3641
Empire State Realty Trust
ESRT
$819M
| $264K | ﹤0.01% |
+18,941
| New | +$266K |
|
3642
PUT
Spectrum Brands
SPB
$2.03B
| $264K | ﹤0.01% |
4,100
| – | – |
|
|
TPTX
3643
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $264K | ﹤0.01% |
+4,241
| New | +$202K |
|
3644
Evertec
EVTC
$1.77B
| $263K | ﹤0.01% |
7,725
-17,808
| -70% | -$564K |
|
3645
PUT
American Express
AXP
$228B
| $261K | ﹤0.01% |
2,100
-27,800
| -93% | -$3.32M |
|
3646
Erie Indemnity
ERIE
$14B
| $261K | ﹤0.01% |
1,575
-923
| -37% | -$163K |
|
|
XOMA
3647
DELISTED
Xoma
XOMA
| $261K | ﹤0.01% |
+9,558
| New | +$214K |
|
3648
National Health Investors
NHI
$3.59B
| $259K | ﹤0.01% |
+3,177
| New | +$260K |
|
3649
PUT
Zoom
ZM
$30.7B
| $259K | ﹤0.01% |
+3,800
| New | +$262K |
|
|
TLRD
3650
DELISTED
Tailored Brands, Inc.
TLRD
| $258K | ﹤0.01% |
62,300
-282,029
| -82% | -$1.33M |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.